SHELBY GEIST: Open Payments
NPI 1437826690 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,197 in 148 payments from 18 companies in 2025. Trend: 2023 $725 · 2024 $963 · 2025 $2,197
Food & beverage: $2,197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $494 |
| Janssen Biotech, Inc. | 20 | $302 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $290 |
| UCB, Inc. | 8 | $261 |
| Novartis Pharmaceuticals Corporation | 19 | $194 |
| Regeneron Healthcare Solutions, Inc. | 14 | $159 |
| Incyte Corporation | 5 | $111 |
| PFIZER INC. | 3 | $55 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $51 |
| Organon LLC | 3 | $44 |
Products named: TREMFYA, RINVOQ, Bimzelx, SKYRIZI, DUPIXENT, ILUMYA, Winlevi, OPZELURA.
Industry payments across IN — which companies pay providers there.
